by Plus Therapeutics | Apr 23, 2024 | PBC
Exciting news yesterday as $PSTV was able to share our recent $3 Million DoD Award for our ReSPECT-PBC Pediatric Brain Cancer Trial. Stock Region Article: https://bit.ly/4b4OBXG #Nasdaq #ClinicalResearch #ClinicalTrial #PediatricOncology...
by Plus Therapeutics | Apr 22, 2024 | PBC
BREAKING NEWS: Plus Therapeutics has been selected for funding by the Department of Defense (DoD) office of the Congressionally Directed Medical Research Programs (CDMRP). The award is expected to commence in Q3 2024 and will support the planned expansion of the...
by Plus Therapeutics | Apr 19, 2024 | LM
Come by our NEW booth at the Living Beyond Breast Cancer Metastatic Breast Cancer Conference this weekend! We have information about Leptomeningeal Metastases and our ongoing ReSPECT-LM Clinical Trial. See you there! 🎗️ ReSPECT-LM Website:...
by Plus Therapeutics | Apr 18, 2024 | Uncategorized
Join some of the Plus Therapeutics team at the Head for the Cure 5K – North Texas on May 4th! They will be out supporting the local community, cancer research, and “Defeating Brain Cancer Step by Step.” We hope to see you there 🏃🏃♂️🏃♀️ Event...
by Plus Therapeutics | Apr 15, 2024 | Uncategorized
#ICYMI: Plus Therapeutics added Dr. Andrew Brenner to our management team. Dr. Brenner will provide substantial input on the Company’s central nervous system cancer development programs while continuing to maintain his academic practice and laboratory. Full Press...
Recent Comments